When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.
Publication
, Journal Article
Barritt, AS; Barnhart, H; Gu, J; Dellinger, A; Rudnick, S; Bonkovsky, HL; DILIN Investigators
Published in: Am J Gastroenterol
December 1, 2023
INTRODUCTION: Diagnosis of drug-induced liver injury (DILI) is difficult. We reviewed cases in the DILI Network prospective study that were adjudicated to have liver injury due to other causes to discover pearls for improved diagnostic accuracy. METHODS: Cases were adjudicated by expert opinion and scored from 1 (definite DILI) to 5 (unlikely DILI). Confirmed cases (1-3) were compared with unlikely cases (5). RESULTS: One hundred thirty-four of the 1,916 cases (7%) were unlikely DILI. Alternative diagnoses were autoimmune hepatitis (20%), hepatitis C (20%), bile duct pathology (13%), and hepatitis E (8%). DISCUSSION: Thorough evaluation, including follow-up, is essential to minimize incorrect diagnosis of idiosyncratic DILI.
Duke Scholars
Published In
Am J Gastroenterol
DOI
EISSN
1572-0241
Publication Date
December 1, 2023
Volume
118
Issue
12
Start / End Page
2301 / 2304
Location
United States
Related Subject Headings
- Prospective Studies
- Liver
- Humans
- Hepatitis C
- Gastroenterology & Hepatology
- Chemical and Drug Induced Liver Injury
- Causality
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Barritt, A. S., Barnhart, H., Gu, J., Dellinger, A., Rudnick, S., Bonkovsky, H. L., & DILIN Investigators. (2023). When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network. Am J Gastroenterol, 118(12), 2301–2304. https://doi.org/10.14309/ajg.0000000000002370
Barritt, A Sidney, Huiman Barnhart, Jiezhun Gu, Andrew Dellinger, Sean Rudnick, Herbert L. Bonkovsky, and DILIN Investigators. “When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.” Am J Gastroenterol 118, no. 12 (December 1, 2023): 2301–4. https://doi.org/10.14309/ajg.0000000000002370.
Barritt AS, Barnhart H, Gu J, Dellinger A, Rudnick S, Bonkovsky HL, et al. When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network. Am J Gastroenterol. 2023 Dec 1;118(12):2301–4.
Barritt, A. Sidney, et al. “When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.” Am J Gastroenterol, vol. 118, no. 12, Dec. 2023, pp. 2301–04. Pubmed, doi:10.14309/ajg.0000000000002370.
Barritt AS, Barnhart H, Gu J, Dellinger A, Rudnick S, Bonkovsky HL, DILIN Investigators. When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network. Am J Gastroenterol. 2023 Dec 1;118(12):2301–2304.
Published In
Am J Gastroenterol
DOI
EISSN
1572-0241
Publication Date
December 1, 2023
Volume
118
Issue
12
Start / End Page
2301 / 2304
Location
United States
Related Subject Headings
- Prospective Studies
- Liver
- Humans
- Hepatitis C
- Gastroenterology & Hepatology
- Chemical and Drug Induced Liver Injury
- Causality
- 3202 Clinical sciences
- 1103 Clinical Sciences